Optimization of Multiplex-PCR Technique To Determine Azf Deletions in infertility Male Patients

DOI: https://doi.org/10.2147/ijgm.s455513
IF: 2.145
2024-04-25
International Journal of General Medicine
Abstract:Tung Nguyen Thanh, 1 Sang Trieu Tien, 2 Phong Nguyen Van, 2 Son Dang Thai, 3 Thuc Luong Cong, 4 Tuan Dinh Le, 5 Son Tien Nguyen, 5 Tuan Tran Van, 1 Hoang Huy Duong, 6 Tien Minh Bui, 7 Kien Trung Nguyen 7 1 Military Institute of Clinical Embryology and Histology, Vietnam Military Medical University, Hanoi, 100000, Vietnam; 2 Department of Biology and Medical Genetics, Vietnam Military Medical University, Hanoi, 100000, Vietnam; 3 Institute of Biological and Food Technology, Hanoi Open University, Hanoi, 100000, Vietnam; 4 Cardiovascular Center, Military Hospital 103, Vietnam Military Medical University, Hanoi, 100000, Vietnam; 5 Department of Rheumatology and Endocrinology, Military Hospital 103, Vietnam Military Medical University, Hanoi, 100000, Vietnam; 6 Department of Neurology, Thai Binh University of Medicine and Pharmacy, Thai Binh, 410000, Vietnam; 7 Department of Obstetrics and Gynecology, Thai Binh University of Medicine and Pharmacy, Thai Binh, 410000, Vietnam Correspondence: Sang Trieu Tien, Department of Biology and Medical Genetics, Vietnam Military Medical University, Hanoi, 100000, Vietnam, Email Background: To optimize the multiplex polymerase chain reaction (M-PCR) technique to diagnose microdeletions of azoospermia factors (AZF) on the Y chromosome and initially apply the technique to diagnose male patients with sperm density less than 5× 10 6 million sperm/mL was assigned to do a test to check for AZF microdeletions on the Y chromosome. Methods: Based on the positive control samples which belong to male subjects who have had 2 healthy children without any assisted reproductive technologies, the M-PCR method was developed to detect simultaneously and accurately AZF microdeletions on 32 male patients with sperm densities below 5× 10 6 million sperm/mL of semen at the Department of Biology and Medical Genetics – Vietnam Military Medical University. Results: Successful optimization of the M-PCR technique including 7 reactions arranged according to each AZFabc region using 24 STS/gene on the Y chromosome. Initial application to diagnose AZF deletion on 32 azoospermic and oligospermic men reveals that AZFa deletion accounts for 6.25% (2/32); deletion of all 3 regions AZFa,b,c with 18.75% (6/32 cases); The combined deletion rate of AZFb,c is highest, accounting for 56.24% (18/32 patients). Conclusion: Successfully optimized the M-PCR technique in identifying AZF microdeletions using 24 sequence tagged sites (STS)/gene for azoospermic and oligozoospermic men. The M-PCR technique has great potential in the application of AZF deletion diagnosis. Keywords: male infertility, azoospermia factors, AZF, multiplex polymerase chain reaction, M-PCR, sequence tagged sites, STS Approximately 15% of couples globally, or 48.5 million couples, experience infertility. 1,2 According to estimated data worldwide, the prevalence of male infertility ranges from about 50% or nearly 30 million men. 1,3 Modifiable factors affecting male infertility have been shown in many studies, such as infections, chronic illnesses, body mass index, environmental toxin exposures, dietary factors and alcohol use. 4,5 In addition, genetic factors are one of the most influential factors in infertility treatment. Accurate diagnosis of the genetic cause of infertility in men remains a formidable task because the spermatogenesis process is governed, controlled, and precisely coordinated by thousands of genes. Small deletions on the Y chromosome, in conjunction with Klinefelter syndrome, are recognised as a common genetic cause of male infertility. 6,7 Small deletions that occur mainly in a specific region on the long arm of the Y chromosome (Yq). In 1976, Tiepolo et al, when studying chromosomal images of male infertility patients, believed that there must be a genetic factor that causes azoospermia, which they called the "azoospermia factor" – AZF) is located on the long arm of chromosome Y. 8 In 1995, Reijo et al determined the location of the AZF region in the distal part of Yq11 and named it the AZF region. 9 From the molecular perspective, the spermatogenesis ability is regulated by genes located in the AZF region and is divided into 3 smaller regions: AZFa, AZFb, and AZFc. 6 A special feature of the boundaries of the AZF regions is the presence of homologous sequences Repeats are susceptible to deletion or duplication through a mechanism called non-allelic homologous recombination (NAHR). Depending on the specific type of AZF deletion, patients will have clinical manifestations of r -Abstract Truncated-
medicine, general & internal
What problem does this paper attempt to address?